+
Site Tour

Epic™ Mitral & Supra Aortic stented tissue valves HCP testimonial

Physicians Vinod Thourani, Eric Charbonneau, Taichi Sakaguchi, and Sven Lehmann share their experience with the Epic™ Mitral and Supra Aortic stented tissue valves.

Related Videos

AV Valves Summit 2024 | Closing of Day 2

Navitor™: Voice of the Experts Francesco Nicolas Dumonteil

Navitor™: Voice of the Experts Federico de Marco

TAVI Case-Club – Alternative access

Navitor™: Voice of the Experts Maurizio Taramasso

Review the Trends | Mitral focus

TAVI Summit - Live case from Berlin

AV VALVES 2023:Decision Making in HF–Tricuspid

TRENDING TOPICS

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

CONNEXT


HUB
RELATED RESOURCES

Epic Mitral – 10-Year Clinical Outcomes

ACC 2023: COAPT™ trial

Data Summary PFO closure in patients > 60 Years

ESC 2021: HF & VHD Guidelines

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023:Decision Making in HF–Tricuspid

TAVI Summit - Cardiac imaging and morphology

AV Valves Summit 2024 | Closing of Day 2

AV VALVES 2023: Trending Topics – Complexity

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline